Skip to content
2000
Volume 11, Issue 2
  • ISSN: 1871-5265
  • E-ISSN: 2212-3989

Abstract

Since the identification of the Human Immunodeficiency Virus (HIV) as the cause of the syndrome of Acquired Immunodeficiency Syndrome (AIDS), there has been an evolution of compounds targeting the replication of the virus in an effort to delay clinical progression. In this review, we revise the mechanism of action of the different groups of drugs. We shortly revisit the older and perhaps lesser used as well as the more recently approved drugs and mention some of the compounds still under investigation.

Loading

Article metrics loading...

/content/journals/iddt/10.2174/187152611795589690
2011-04-01
2025-04-18
Loading full text...

Full text loading...

/content/journals/iddt/10.2174/187152611795589690
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test